Joint ASTCT-EBMT Basic and Translational Scientific Retreat

   

The American Society for Transplantation and Cellular Therapy (ASTCT) and EBMT are proud to announce the Inaugural 2021 Joint ASTCT-EBMT Basic and Translational Scientific Retreat, taking place October 13 – 15, 2021.

The Basic and Translational Scientific Retreat will be a 2.5-day conference focused on cutting edge basic and translational biology in the field. The meeting will focus on fundamental themes and novel technologies with an emphasis on unpublished and innovative science. Attendance to the meeting will be limited to 100 attendees with afternoon breaks to allow for informal networking opportunities between junior and senior attendees. The meeting will host two days of poster sessions and a best oral abstract session. 

Health & Safety Registration Agenda

DETAILS:

Joint ASTCT – EBMT Basic and Translational Scientific Retreat
October 13 – October 15, 2021
Vail Marriott Mountain Resort
Vail, Colorado, United States

HEALTH & SAFETY:

ASTCT and EBMT are continuing to monitor recommendations from the CDC and WHO. For COVID-19 updates and what to expect at the Vail Marriott Mountain Resort, please visit: https://whattoexpect.marriott.com/whrco

Face coverings will be required in all indoor public areas.

TRAVEL ARRANGEMENTS:

Attendees can fly into the following airports.

  • Denver International Airport to Vail Marriott Mountain Resort: 2 hours 3 minutes (121 miles)
  • Eagle Vail County Regional Airport to Vail Marriott Mountain Resort: 37 minutes (33.9 miles)

If you opt to fly into the Denver International Airport, shuttle options will be provided. Additional details regarding the shuttles are forthcoming.

HOUSING:

ASTCT and EBMT have reserved rooms at a discounted rate at the Vail Marriott Mountain Resort. The discounted rate will be available through September 15 or until the group block is sold out. A credit card is required to hold each individual’s reservation. If you are unable to honor your reservation, you must cancel within 48 hours prior to your arrival date or your first night's room and tax will be retained.

Room Rate: $185.00 (includes tax) plus $20 resort fee.

Information on how to make a hotel reservation will be distributed in the registration confirmation email.

Return to top

TARGET AUDIENCE:

The program is intended for both junior and senior members of the blood and marrow transplantation and cellular therapy field.

REGISTRATION:

Registration to this event is limited to a maximum of 100 total attendees. We are unable to accept additional registrants once the registration capacity has been met.  

This conference is only for physicians and scientists who are currently practicing in the field of transplantation and cellular therapy and sponsoring companies. Please contact Angie Dahl (adahl@astct.org) if you are interested in participating as a sponsor. 

Register

Type

Price

Junior Attendee Rate*

$125

Senior Attendee Rate

$250 


*Junior attendees are defined as post doctoral fellows, current fellows, and junior faculty within the first three years of appointment.


Return to top

*PROGRAM AGENDA:

The program agenda will be broken into three main session topics – Gene editing, GVL, and GVHD. Attendees will have an extended afternoon break to network and explore Vail, Colorado. MT=US Mountain Time Zone.


Day 1: Wednesday, October 13, 2021; Gene Editing

Session Chairs: Harry Dolstra, PhD, Bruce Blazar, MD, and Leslie Kean, MD, PhD

Time

Topic

8:00 – 9:00AM MT

Genome editing for immune deficiencies – efficacy and safety

Toni Cathomen, PhD; University of Freiburg, Freiburg, DE

9:00 – 10:00AM MT

Genome Editing of the Blood: Precise and Potent Cell Based Therapies

Matthew Poretus, MD, PhD; Stanford Medicine, CA, US

10:00 – 10:30AM MT

Break

10:30 – 11:30AM MT

Development and Application of Targeted Epigenetic Editing

Angelo Lombardo, PhD; IRCCS Ospedale San Raffaele, Milano, IT

11:30 – 12:30PM MT

Expanding the Horizons of Genome Interventions with CRISPR Tools

Anna Cereseto, PhD; University of Trento, Trento, IT

12:30 – 4:30PM MT

Afternoon break – lunch will be available beginning at 12:30PM.

4:30 – 5:30PM MT

Podium Discussion

5:30 – 6:30PM MT

Poster Hall + Networking Hour

6:30 – 7:30PM MT
(Dinner Session)

Dinner + lecture

Speaker: Helen E Heslop, M.D., DSc.; Baylor College of Medicine, Houston, TX

 

Day 1 concludes

 

Day 2: Thursday, October 14, 2021; Graft-versus-Leukemia

Session Chairs: Chiara Bonini, MD and Warren Shlomchik, MD

Time

Topic

8:00 – 9:00AM MT

Biological Mechanisms and Personalized Therapy of Post-Transplantation Leukemia Relapses

Luca Vago, MD, PhD, San Raffaele Scientific Institute, Milan, IT

9:00 – 10:00AM MT

Mechanisms of GVL Resistance

Warren Shlomchik, MD; University of Pittsburgh, PA, US

10:00 – 10:30AM MT

Break

10:30 – 11:30AM MT

Immune Escape Mechanisms Causing AML Relapse After Allo-HCT

Robert Zeisser, MD; University of Freiburg, Breisgau, DE

11:30 – 12:30PM MT

Treating AML with Engineered T cells: Identifying Obstacles to Efficacy and Designing Solutions

Philip Greenberg, MD; Fred Hutchinson Cancer Research Center, Seattle, WA, US

12:30 – 4:30PM MT

Afternoon break – lunch will be available beginning at 12:30PM.

4:30 – 5:30PM MT

Meet-the-Professor Session

5:30 – 6:30PM MT

Poster Hall + Networking Hour

6:30 – 7:30PM MT
(Dinner Session)

Transcriptional Networks in Tumour-Infiltrating T Cells

Speaker: Anjana Rao, PhD; La Jolla Institute for Immunology, La Jolla, CA, US

 

Day 2 concludes

 

 

Day 3: Friday, October 15, 2021; Graft-versus-Host disease

Session Chairs: Pavan Reddy, MD and Nicolaus Kröger, MD

Time

Topic

8:00 – 9:00AM MT

Mechanism of Liver Stem Cell Injury in GVHD - Therapeutic Implications and Interventions

Takanori Teshima, MD, PhD; Hokkaido University, Sapporo, JP

9:00 – 10:00AM MT

Next Challenges in GHVD: From Bedside back to the Bench

Gerard Socié, MD, PhD; Hôpital Saint-Louis, Paris, FR

10:00 – 10:30AM MT

Break

10:30 – 11:30AM MT

The Microbiome and Graft vs Host Disease

Marcel van den Brink, MD, PhD; Memorial Sloan Kettering Cancer Center, New York City, NY, US

11:30 – 12:45PM MT

Best Abstracts

12:45 – 1:00PM MT

Closing remarks; conference wrap up

 

Day 3 concludes

 

*Please note: session titles and speakers are subject to change. The agenda will be updated as additional information is confirmed.

Return to top

Sponsor Opportunities

If you are interested in sponsoring this event, please contact Angie Dahl.